Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

Also called NCT02244879

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02244879
Other papers using this trial's data
  • Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial Acta diabetologica, 2017-05 DOI, PubMed 28238190
  • Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation Acta diabetologica, 2018-04 DOI, PubMed 29330620, PMC5851693 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02244879. Randomized; triple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients
Condition
Type 2 Diabetes Mellitus
Condition
Inflammation
Condition
Other Disorders of Bone Density and Structure
Intervention (Dietary supplement)
resveratrol
Lead sponsor
University of Turin, Italy (class: other)
Collaborator
Ministry of Health, Italy (class: other government)

Record details

Record id
cardio:ct-nct02244879
Content hash
3f13e8818d479e95b8161e4022ebad528e20e63c76305ab2a087f1fe5686c342